Nanalysis Scientific Corp. (FRA:1N1)
Germany
· Delayed Price · Currency is EUR 0.0985
0.00 (0.00%)
At close: Dec 4, 2025
Nanalysis Scientific Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 41.74 | 45.5 | 28.47 | 24.82 | 16.04 | 7.87 | Upgrade
|
| Revenue Growth (YoY) | -2.93% | 59.82% | 14.69% | 54.72% | 103.75% | -5.86% | Upgrade
|
| Cost of Revenue | 30.49 | 32.75 | 24.5 | 14.35 | 5.8 | 2.71 | Upgrade
|
| Gross Profit | 11.26 | 12.75 | 3.97 | 10.47 | 10.24 | 5.17 | Upgrade
|
| Selling, General & Admin | 10.25 | 10.27 | 11.37 | 12.94 | 7.69 | 6.34 | Upgrade
|
| Research & Development | 0.47 | 0.54 | 0.68 | 1.47 | 0.64 | 0.48 | Upgrade
|
| Operating Expenses | 15 | 16.19 | 17.46 | 20.52 | 11.43 | 8.91 | Upgrade
|
| Operating Income | -3.74 | -3.45 | -13.49 | -10.06 | -1.19 | -3.74 | Upgrade
|
| Interest Expense | -1.25 | -1.35 | -0.28 | -0.08 | - | - | Upgrade
|
| Interest & Investment Income | 0.03 | - | - | - | 0 | 0.33 | Upgrade
|
| Earnings From Equity Investments | -0.35 | -1.09 | -0.53 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | -0.03 | -0.17 | -0.16 | -0.04 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.5 | -0.5 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -5.79 | -6.4 | -14.46 | -10.3 | -1.23 | -3.43 | Upgrade
|
| Merger & Restructuring Charges | -0.2 | -0.31 | 0.53 | -0.1 | -0.19 | -0.27 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.64 | -4.64 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.08 | -0.09 | -2.86 | - | - | - | Upgrade
|
| Asset Writedown | -1.19 | -1.46 | - | - | - | - | Upgrade
|
| Other Unusual Items | -0.47 | -0.73 | - | - | -0.35 | -0.28 | Upgrade
|
| Pretax Income | -12.37 | -13.64 | -16.8 | -10.4 | -1.77 | -3.98 | Upgrade
|
| Income Tax Expense | 0.01 | -0.02 | -0.01 | -0.48 | - | -0.3 | Upgrade
|
| Earnings From Continuing Operations | -12.38 | -13.61 | -16.78 | -9.92 | -1.77 | -3.68 | Upgrade
|
| Minority Interest in Earnings | - | - | 0.59 | 0.81 | - | - | Upgrade
|
| Net Income | -12.38 | -13.61 | -16.2 | -9.1 | -1.77 | -3.68 | Upgrade
|
| Net Income to Common | -12.38 | -13.61 | -16.2 | -9.1 | -1.77 | -3.68 | Upgrade
|
| Shares Outstanding (Basic) | 114 | 111 | 99 | 92 | 70 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 114 | 111 | 99 | 92 | 70 | 65 | Upgrade
|
| Shares Change (YoY) | 5.53% | 11.56% | 7.25% | 31.35% | 7.77% | 17.42% | Upgrade
|
| EPS (Basic) | -0.11 | -0.12 | -0.16 | -0.10 | -0.03 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.11 | -0.12 | -0.16 | -0.10 | -0.03 | -0.06 | Upgrade
|
| Free Cash Flow | 1.69 | 3.21 | -11.92 | -10.67 | -1.79 | -1.05 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.03 | -0.12 | -0.12 | -0.03 | -0.02 | Upgrade
|
| Gross Margin | 26.96% | 28.02% | 13.95% | 42.18% | 63.83% | 65.62% | Upgrade
|
| Operating Margin | -8.97% | -7.57% | -47.38% | -40.51% | -7.42% | -47.51% | Upgrade
|
| Profit Margin | -29.66% | -29.92% | -56.90% | -36.67% | -11.04% | -46.71% | Upgrade
|
| Free Cash Flow Margin | 4.05% | 7.05% | -41.88% | -43.00% | -11.18% | -13.33% | Upgrade
|
| EBITDA | -5.68 | -2.41 | -12.33 | -8.81 | -0.57 | -3.18 | Upgrade
|
| EBITDA Margin | -13.61% | -5.30% | -43.32% | -35.47% | -3.58% | -40.34% | Upgrade
|
| D&A For EBITDA | -1.94 | 1.03 | 1.16 | 1.25 | 0.62 | 0.57 | Upgrade
|
| EBIT | -3.74 | -3.45 | -13.49 | -10.06 | -1.19 | -3.74 | Upgrade
|
| EBIT Margin | -8.97% | -7.57% | -47.38% | -40.51% | -7.42% | -47.51% | Upgrade
|
| Revenue as Reported | 41.74 | 45.5 | 28.47 | 24.82 | 16.04 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.